They're exploring its use for groundbreaking treatments for cancer and autoimmune disease, as well as for gene-editing ...
Q3 2025 Earnings Call Transcript October 29, 2025 BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0 ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
According to the HSRC report, Gross Domestic Expenditure on Research and Development (GERD) stood at R43.413 billion in ...
Asianet Newsable on MSN
FDA To Ease Review Process For Life-Saving Gene-Editing Therapies: Report
Vinay Prasad told Bloomberg that the FDA is going to be “extremely flexible” regarding gene editing therapies.
A top US regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback